PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25028149-5	2014	The in silico docking study has provided an insight and evidence for the antineoplastic activity of monocrotaline against p53, HGF and TREM1 proteins which play a threatening role in causing hepatocellular carcinoma.	Monocrotaline	100-113	hepatocyte growth factor	Homo sapiens	127-130	
15541968-2	2004	In this study, we investigated whether human HGF gene transfer may attenuate the medial hypertrophy of pulmonary arteries and enhance the ameliorating effect of prostacyclin in monocrotaline (MCT)-induced pulmonary hypertension in rats.	Monocrotaline	177-190	hepatocyte growth factor	Homo sapiens	45-48	
25674243-0	2014	Transfer of human hepatocyte growth factor reduces inflammation and prevents pulmonary arterial remodeling in monocrotaline-induced.	Monocrotaline	110-123	hepatocyte growth factor	Homo sapiens	18-42	
25674243-2	2014	This study was to investigate the therapeutic effect of human hepatocyte growth factor (HGF) gene transfer on monocrotaline (MCT) induced PAH rat models.	Monocrotaline	110-123	hepatocyte growth factor	Homo sapiens	62-86	
25674243-2	2014	This study was to investigate the therapeutic effect of human hepatocyte growth factor (HGF) gene transfer on monocrotaline (MCT) induced PAH rat models.	Monocrotaline	110-123	hepatocyte growth factor	Homo sapiens	88-91	
25674243-2	2014	This study was to investigate the therapeutic effect of human hepatocyte growth factor (HGF) gene transfer on monocrotaline (MCT) induced PAH rat models.	Monocrotaline	125-128	hepatocyte growth factor	Homo sapiens	62-86	
25674243-2	2014	This study was to investigate the therapeutic effect of human hepatocyte growth factor (HGF) gene transfer on monocrotaline (MCT) induced PAH rat models.	Monocrotaline	125-128	hepatocyte growth factor	Homo sapiens	88-91